Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKCOM Regulatory News (KCOM)

  • There is currently no data for KCOM

Director/PDMR Shareholding

20 Nov 2009 11:59

RNS Number : 8516C
KCom Group PLC
20 November 2009
 



Grant of share awards to senior management

KCOM Group plc ('the Company') reports that the Remuneration Committee of the Board met on 19 November 2009 and agreed to the grant of awards of shares of the Company to a number of senior employees utilising the 'Executive Incentive Plan.'

All awards were granted as a nil cost conditional award in the Company. The awards cannot normally be released until the 3rd, 4th and 5th anniversary of the date of grant.

Information in respect to the awards to persons discharging managerial responsibilities is set out in the following DTR 3.1.4 R notification.

Annex DTR3

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

All relevant boxes should be completed in block capital letters.

1.

Name of the issuer

KCOM Group PLC

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R, 

(ii) a disclosure made in accordance 

LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

DTR 3.1.2 R

3.

Name of person discharging managerial

responsibilities/director

SEAN ROYCE

STEVE DENMARK

RICHARD BLAND

DAVID BISHOP

DEAN BRANTON

4.

State whether notification relates to a person

connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial

interest 1

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8.

State the nature of the transaction

9.

Number of shares, debentures or financial

instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

11.

Number of shares, debentures or financial

instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

13.

Price per share or value of transaction

14.

Date and place of transaction

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

If a person discharging managerial responsibilities has been granted options by the issuer

complete the following boxes

17.

Date of grant

19 NOVEMBER 2009

18.

Period during which or date on which exercisable

VESTED SHARES SHALL BE RELEASED IN RESPECT OF 50% 3 YEARS AFTER THE DATE OF GRANT, IN RESPECT OF 25% 4 YEARS AFTER THE DATE OF GRANT AND IN RESPECT OF THE FINAL 25% 5 YEARS AFTER THE DATE OF GRANT.

19.

Total amount paid (if any) for grant of the option

NIL

20.

Description of shares or debentures involved (class and number)

CONDITIONAL AWARDS OVER ORDINARY SHARES OF 10 PENCE EACH

SEAN ROYCE - 631,850

STEVE DENMARK - 631,850

RICHARD BLAND - 477,850

DAVID BISHOP - 477,850

DEAN BRANTON - 367,850

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise

THE PECENTAGE OF AWARD SHARES THAT BECOME VESTED AWARD SHARES ON THE VESTING DATE SHALL BE CALCULATED BASED ON THE HIGHEST TSR DURING THE AWARD PERIOD. AT 45 PENCE, 10% OF AWARD SHARES WILL VEST. BETWEEN 45 PENCE AND 100 PENCE, VESTING WILL TAKE PLACE ON A "STRAIGHT LINE" BASIS BETWEEN 10% AND 100%. 100 PENCE AND OVER, 100% OF AWARD SHARES WILL BECOME VESTED SHARES. ALL VESTING IS SUBJECT TO THE DISCRETION OF THE REMUNERATION COMMITTEE THAT THE COMMITTEE IS SATISFIED THERE HAS ALSO BEEN A DEMONSTRABLE AND SUSTAINED IMPROVEMENT IN THE COMPANY'S PERFORMANCE BETWEEN THE DATE OF GRANT AND THE RELEVANT VESTING DATE.

22.

Total number of shares or debentures over which options held following notification

SEAN ROYCE - 631,850

STEVE DENMARK - 631,850

RICHARD BLAND - 477,850

DAVID BISHOP - 477,850

DEAN BRANTON - 367,850

23.

Any additional information

24.

Name of contact and telephone number for queries

NICOLA MILLER - 01924 882839

Name of authorised official of issuer responsible for making notification: PAUL SIMPSON 

Date of notification 20 NOVEMBER 2009

Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBMBBTMMATBPL
Date   Source Headline
1st Jul 201510:17 amRNSAnnual Financial Report
12th Jun 201511:47 amRNSDirector/PDMR Shareholding
5th Jun 20157:00 amRNSFinal Results
1st Jun 20152:26 pmRNSDirector Declaration
20th May 20154:02 pmRNSAppointment-Joint Financial Adviser & Joint Broker
12th May 20155:10 pmRNSDirector/PDMR Shareholding
13th Apr 20154:43 pmRNSDirector/PDMR Shareholding
7th Apr 201510:02 amRNSDirectorate Change
1st Apr 20155:38 pmRNSHolding(s) in Company
26th Mar 20153:30 pmRNSEmployee Benefit Trust Dealing
26th Mar 20157:00 amRNSPre-close Statement
16th Mar 201510:06 amRNSDirector/PDMR Shareholding
13th Feb 201511:14 amRNSDirector/PDMR Shareholding
5th Feb 20154:01 pmRNSDirector/PDMR Shareholding
2nd Feb 20159:56 amRNSBlocklisting Interim Review
13th Jan 20159:32 amRNSDirector/PDMR Shareholding
5th Jan 201510:22 amRNSDirector Appointment
15th Dec 20148:56 amRNSDirector/PDMR Shareholding
25th Nov 20147:00 amRNSHalf Yearly Report
19th Nov 201411:27 amRNSEmployee Benefit Trust Dealing
12th Nov 20141:26 pmRNSDirector/PDMR Shareholding
13th Oct 20144:45 pmRNSDirector/PDMR Shareholding
30th Sep 20147:00 amRNSPre-close Statement
11th Sep 20143:55 pmRNSDirector/PDMR Shareholding
11th Aug 20145:08 pmRNSDirector/PDMR Shareholding
7th Aug 20144:07 pmRNSDirector/PDMR Shareholding
1st Aug 20149:03 amRNSBlocklisting Interim Review
31st Jul 20142:42 pmRNSDirector/PDMR Shareholding
31st Jul 20142:41 pmRNSDirector/PDMR Shareholding
29th Jul 20143:03 pmRNSDirector/PDMR Shareholding
29th Jul 20142:01 pmRNSResult of AGM
29th Jul 201412:37 pmRNSRetirement of Director
29th Jul 20147:00 amRNSInterim Management Statement
18th Jul 201411:38 amRNSDirector/PDMR Shareholding
16th Jul 20144:47 pmRNSEmployee Benefit Trust Dealing
14th Jul 20142:01 pmRNSDirector/PDMR Shareholding
10th Jul 20144:33 pmRNSAnnual Financial Report
16th Jun 20145:13 pmRNSEmployee Benefit Trust Dealing
13th Jun 201412:07 pmRNSDirector/PDMR Shareholding
6th Jun 20147:00 amRNSFinal Results
14th May 20147:00 amRNSDirector/PDMR Shareholding
14th Apr 20149:59 amRNSDirector/PDMR Shareholding
25th Mar 20147:00 amRNSPre-close statement
17th Mar 201411:57 amRNSHolding(s) in Company
12th Mar 20144:36 pmRNSDirector/PDMR Shareholding
12th Feb 20149:56 amRNSDirector/PDMR Shareholding
10th Feb 20143:56 pmRNSDirector/PDMR Shareholding
5th Feb 20149:35 amRNSDirector Declaration
3rd Feb 20147:00 amRNSBlocklisting Interim Review
31st Jan 20143:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.